Key points are not available for this paper at this time.
Precision medicine is making an impact on patients, health care delivery systems, and research participants in ways that were only imagined fifteen years ago when the human genome was first sequenced. Discovery of disease-causing and drug-response genetic variants has accelerated, while adoption into clinical medicine has lagged. We define precision medicine and the stakeholder community required to enable its integration into research and health care. We explore the intersection of data science, analytics, and precision medicine in the formation of health systems that carry out research in the context of clinical care and that optimize the tools and information used to deliver improved patient outcomes. We provide examples of real-world impact and conclude with a policy and economic agenda necessary for the adoption of this new paradigm of health care both in the United States and globally.
Building similarity graph...
Analyzing shared references across papers
Loading...
Geoffrey S. Ginsburg
General Cardiology
Kathryn A. Phillips
University of California, San Francisco
Health Affairs
Duke University
California Health and Human Services Agency
Building similarity graph...
Analyzing shared references across papers
Loading...
Ginsburg et al. (Tue,) studied this question.
synapsesocial.com/papers/69dac18c0d8d6ef495a3bf86 — DOI: https://doi.org/10.1377/hlthaff.2017.1624
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: